Video

Are urologists counseling patients on smoking cessation?

Author(s):

Urology Times staff

“Very, very few patients actually had any counseling documented or any medications ordered that would help with smoking cessation,” says Richard S. Matulewicz, MD.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Richard S. Matulewicz, MD, discusses the recent Journal of Urology paper, “Tobacco screening and treatment during outpatient urologic office visits in the United States,” for which he served as a study author. Matulewicz is a clinical instructor in urology at NYU Grossman School of Medicine.

      Related Videos
      Human kidney stones | Image Credit: © freshidea - stock.adobe.com
      Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
      De novo metastatic prostate cancer: Understanding Biden’s prognosis and treatment
      De novo metastatic prostate cancer: Understanding Biden’s prognosis and treatment
      Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
      Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
      Woman talking with doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
      Alternative treatments and patient communication for genitourinary syndrome of menopause
      Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
      Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
      Prostate cancer screening: Expert weighs in after Biden's diagnosis
      Prostate cancer screening: Expert weighs in after Biden's diagnosis
      Sarah Razavi, MD, answers a question during a Zoom video interview
      Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists
      Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
      Study results affirm effectiveness of evolving prostate cancer therapies
      Laura Davis, MD, on link between microplastics and bladder cancer
      Laura Davis, MD, on link between microplastics and bladder cancer
      Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
      Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
      Related Content
      Prostate Gland - (BPH) Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
      December 26th 2024

      Top 10 BPH articles and videos of 2024

      Benjamin P. Saylor
      As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia.
      Crystal light - stock.adobe.com
      March 4th 2022

      Efficacy of batiraxcept/cabozantinib combo in clear cell RCC: Updated results

      Janelle Hart
      Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
      February 7th 2022

      Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer

      Janelle Hart
      To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
      How appropriate use criteria for PSMA-PET imaging optimize patient care
      February 2nd 2022

      How appropriate use criteria for PSMA-PET imaging optimize patient care

      Janelle Hart
      In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
      Dr. Chee summarizes latest Optilume data in patients with urethral strictures
      November 9th 2021

      Dr. Chee summarizes latest Optilume data in patients with urethral strictures

      Urology Times staff
      "Certainly, the Optilume drug-coated balloon appears to be safe and effective in roughly two-thirds of patients at 3 years," said Justin Chee, MD.
      Dr. Declan G. Murphy describes the background of PSMA PET/CT in prostate cancer
      December 16th 2020

      Dr. Declan G. Murphy describes the background of PSMA PET/CT in prostate cancer

      Urology Times staff
      Murphy shares the backstory of how PSMA PET/CT imaging has emerged as a major advancement in the prostate cancer armamentarium.
      © 2025 MJH Life Sciences

      All rights reserved.